Cytochrome P450 (CYP) Phenotyping of Aficamten, a Next in class Inhibitor of Cardiac Myosin, Using Human Liver Microsomes and Human Recombinant CYP Enzymes

Cytokinetics Incorporated published this content on October 06, 2024, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on October 06, 2024 at 08:45 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at support@pubt.io